Angiotensin II
- Generic Name
- Angiotensin II
- Brand Names
- Giapreza
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 4474-91-3
- Unique Ingredient Identifier
- M089EFU921
- Background
Angiotensin II is under investigation for the treatment of Sepsis, Septic Shock, Diabetes Mellitus, and Acute Renal Failure. Angiotensin II has been investigated for the treatment, basic science, and diagnostic of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy.
...
- Indication
Angiotensin II is a vasoconstrictor indicated for increasing blood pressure in adults with septic or other distributive shock .
- Associated Conditions
- Hypotension
- Associated Therapies
- -
Genetic Mechanisms in Human Hypertension
- Conditions
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT01456208
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Caveolin-1 and Vascular Dysfunction
- Conditions
- Interventions
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT01426529
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- George Washington University
- Target Recruit Count
- 20
- Registration Number
- NCT01393782
- Locations
- 🇺🇸
GW University, Washington, District of Columbia, United States
Interaction of Apelin and Angiotensin in the Systemic Circulation
- Conditions
- Interventions
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2010-08-10
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 12
- Registration Number
- NCT01049646
- Locations
- 🇬🇧
Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc, Edinburgh, United Kingdom
Role of Angiotensin II in Insulin-induced Microvascular Activity
- Conditions
- Interventions
- First Posted Date
- 2009-12-02
- Last Posted Date
- 2009-12-02
- Lead Sponsor
- Maastricht University Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT01024543
- Locations
- 🇳🇱
Maastricht University Medical Centre, Maastricht, P.o. Box 5800, Netherlands, Netherlands
The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
- Conditions
- Interventions
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT00962949
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Interaction of Apelin and Angiotensin in the Human Forearm Circulation
- Conditions
- Interventions
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2010-08-10
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 12
- Registration Number
- NCT00901745
- Locations
- 🇬🇧
Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc, Edinburgh, United Kingdom
Angiotensin in Septic Kidney Injury Trial
- Conditions
- Interventions
- First Posted Date
- 2008-07-09
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- Austin Health
- Target Recruit Count
- 12
- Registration Number
- NCT00711789
- Locations
- 🇦🇺
The Western Hospital, Footscray, Victoria, Australia
🇦🇺Northern Hospital, Epping, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.